REN and pulmonary arterial hypertension: Our study demonstrates the additional effects of monocrotaline: activation of the alternative pathway of the renin–angiotensin system, downregulation of aldosterone, and modifications in erythrocyte Na,K-ATPase kinetics in a monocrotaline-induced rat model of PAH.